Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
XENE
XENE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
XENE News
Xenon Pharmaceuticals Reports Positive Phase 3 X-TOLE2 Study Results
1d ago
seekingalpha
Xenon Pharmaceuticals Stock Soars 44% Following Successful Late-Stage Trial of Epilepsy Drug
1d ago
moomoo
Wall Street Analysts Adjust Ratings
5h ago
Benzinga
Xenon Pharmaceuticals Stock Surpasses Analyst Target Price
9h ago
NASDAQ.COM
Xenon Plans New Drug Application Submission
20h ago
stocktwits
Xenon and Relmada Surge on Positive Drug Data
21h ago
Yahoo Finance
Xenon Pharmaceuticals Launches $500 Million Public Offering
1d ago
seekingalpha
U.S. Stocks Close Sharply Lower Amid Mixed Trading
1d ago
Benzinga
Oil Price Surge Drives Significant Stock Movements
1d ago
CNBC
Biohaven Shares Fluctuate Following Positive Study Data
1d ago
Benzinga
Relmada Therapeutics Shares Surge 40.8% on Promising Trial Data
1d ago
Benzinga
Xenon Pharmaceuticals Reports Positive Phase 3 X-TOLE2 Study Results
1d ago
Benzinga
U.S. Stocks Drop Over 1% in Morning Trading
1d ago
Benzinga
Xenon Pharmaceuticals' X-TOLE2 Study Achieves Success
1d ago
NASDAQ.COM
Xenon Pharmaceuticals Executive States Azetukalner's Data and Innovative Mechanism Require Adjusted Pricing, Notes Previous Therapy Was "Underpriced" - Conference Call
1d ago
moomoo
Xenon Pharmaceuticals to Announce Phase 3 Data for Azetukalner
2d ago
Newsfilter
Show More News
